- Home
- / Lepu Biopharma
Lepu Biopharma
Stock Price
$3.1
2024-10-29
Market Capitalization
$5.2 B
2024-10-29
Revenue
¥225.4 M
FY, 2023
Lepu Biopharma Summary
Company Summary
- Overview
- Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics. It develops a pipeline of drug candidates including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
- Type
- Public
- Status
- Active
- Founded
- 2018
- HQ
- HK | view all locations
- Cybersecurity rating
Table of Contents
Lepu Biopharma Financials
Summary Financials
- Revenue (H1, 2024)
- ¥133.3M
- Gross profit (H1, 2024)
- ¥112.9M
- Net income (H1, 2024)
- (¥197.0M)
- Cash (H1, 2024)
- ¥513.6M
- EBIT (H1, 2024)
- (¥191.1M)
- Enterprise value
- $5.5B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025